ClinicalThought

Share

Program Content

Activities

  • NSCLC: Current and Emerging Testing
    What Must Be Tested in NSCLC Today and Likely Tomorrow
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 11, 2022

    Expires: July 10, 2023

    View Activity
  • FAQs: Biomarker Testing in NSCLC
    FAQs: Importance of Biomarker Testing in NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 31, 2022

    Expires: August 30, 2023

    View Activity
  • NSCLC: Trastuzumab Deruxtecan
    Trastuzumab Deruxtecan for Our Patients With HER2 Mutation–Positive Advanced NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 12, 2022

    Expires: September 11, 2023

    View Activity
  • NSCLC: Experts Address FAQs
    FAQs: New Directions in Biomarker Testing in the Management of NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 17, 2022

    Expires: October 16, 2023

    View Activity

Faculty

cover img faculity

Matthew Gubens, MD, MS

Associate Professor
Thoracic Oncology
University of California, San Francisco
San Francisco, California

cover img faculity

Craig Mackinnon, MD, PhD

Professor
Direct Division of Genomic Diagnostics and BioInformatics
University of Alabama at Birmingham
Birmingham, Alabama

Provided by

ProCE Banner

Supporters

AstraZeneca

Bayer Healthcare Pharma

Daiichi Sankyo, Inc.

Genentech TEXT Only

Janssen administered by Scientific Affairs

Lilly

Novartis Pharmaceuticals Corporation

Partners

AMP

ProCE Banner